Biocryst Pharmaceuticals buy HC Wainwright
Start price
07.05.24
/
50%
€4.98
Target price
07.05.25
€27.83
Performance (%)
47.34%
Price
05.09.24
€7.34
Summary
This prediction is currently active. The BUY prediction by HC_Wainwright for Biocryst Pharmaceuticals has seen massive gains of 47.34%. This prediction currently runs until 07.05.25. The prediction end date can be changed by HC_Wainwright at any time. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Biocryst Pharmaceuticals | -5.925% | -5.925% |
iShares Core DAX® | -1.414% | 7.218% |
iShares Nasdaq 100 | -2.316% | 4.450% |
iShares Nikkei 225® | -2.756% | 10.071% |
iShares S&P 500 | -1.849% | 4.760% |
Comments by HC_Wainwright for this prediction
In the thread Biocryst Pharmaceuticals diskutieren
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
Ratings data for BCRX provided by MarketBeat
Stopped prediction by HC_Wainwright for Biocryst Pharmaceuticals
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€7.20
06.08.24
06.08.24
€27.50
06.08.25
06.08.25
1.95%
05.09.24
05.09.24
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€6.90
04.08.23
04.08.23
€27.22
04.08.24
04.08.24
-7.45%
05.08.24
05.08.24